PerkinElmer Inc. acquired private German company EuroImmun AG (autoimmune, infectious disease, and allergy testing) for $1.3bn (which is more than four times EuroImmun's expected 2017 revenues of $310mm). (Jun.)
PE will use cash on hand and about $900mm via an existing revolving debt facility to pay for the all-cash transaction. Founded in 1987, EuroImmun offers systems (based on its...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?